Introduction
============

*Citrobacter freundii*, a member of the family *Enterobacteriaceae*, is widely found in the environment as well as in the intestinal tract of humans and animals. *C. freundii* is generally considered a low-grade opportunistic pathogen that rarely causes infections, but it has been associated with a wide spectrum of infections of the central nervous system, the respiratory, gastrointestinal, urinary and respiratory tracts, the blood, and many other normally sterile sites in neonates and immunocompromised patients.[@b1-idr-11-1447]

Plasmid-mediated multi-drug resistance (MDR) has been widely found in *C. freun-dii*. This study disclosed the co-occurrence of five resistance plasmids pP10159-1, pP10159-2, pP10159-3, pP10159-4 and pP10159-5, containing a total of 24 different resistance markers, in a single clinical *C. freundii* isolate.

Materials and methods
=====================

Bacterial strain
----------------

The use of human specimens and all related experimental protocols were approved by the Committee on Human Research of Southwest Hospital, and carried out in accordance with the approved guidelines. The indicated patient signed a written informed consent.

*C. freundii* P10159 was isolated in 2013 from a midstream urine specimen from an esophageal cancer patient with hospital-acquired postoperative urinary tract infection from a teaching hospital in Chongqing City, China. Bacterial species identification was performed using Bruker MALDI Biotyper (Bruker Daltonics) and 16S rRNA gene sequencing.[@b2-idr-11-1447] The sequence type (ST) of P10159 was determined based on the *C. freundii* multilocus sequence typing (MLST) scheme (<https://pubmlst.org/cfreundii/>). All PCR amplicons were sequenced on an ABI 3730 Sequencer.

Genomic DNA sequencing and plasmid sequence assembly
----------------------------------------------------

Bacterial genomic DNA was isolated using a Qiagen large construct kit and sequenced from a paired-end library with a mate-pair library with average insert size of 5 kb (ranging from 2 to 10 kb) at a mean coverage 108, using a MiSeq sequencer (Illumina, CA, USA). Reads were trimmed to remove poor quality sequences. In order to get the complete plasmid sequences, DNA contigs were assembled based on their contig coverage using Newbler 2.8.[@b3-idr-11-1447] Gaps between contigs were filled using a combination of PCR and Sanger sequencing using an ABI 3730 Sequencer.

Sequence annotation and genome comparison
-----------------------------------------

Open reading frames and pseudogenes were predicted using RAST 2.0[@b4-idr-11-1447] combined with BLASTP/BLASTN searches against the UniProtKB/Swiss-Prot[@b5-idr-11-1447] and RefSeq[@b6-idr-11-1447] databases. Annotation of resistance genes, mobile elements and other features was carried out using CARD,[@b7-idr-11-1447] ResFinder,[@b8-idr-11-1447] ISfinder[@b9-idr-11-1447] and INTEGRALL.[@b10-idr-11-1447] Multiple and pairwise sequence comparisons were performed using MUSCLE 3.8.31[@b11-idr-11-1447] and BLASTN, respectively. Gene organization diagrams were drawn in Inkscape 0.48.1 (<https://inkscape.org/en/>).

Plasmid conjugal transfer
-------------------------

Plasmid conjugal transfer experiments were carried out with the rifampin-resistant *Escherichia coli* EC600 being used as recipient and the P10159 strain as donor. Three milliliters of overnight cultures of each of donor and recipient bacteria were mixed together, harvested and resuspended in 80 µL of Brain Heart Infusion (BHI) broth (BD Biosciences). The mixture was spotted on a 1 cm^2^ hydrophilic nylon membrane filter with a 0.45 µm pore size (Millipore) that was placed on a BHI agar (BD Biosciences) plate and then incubated for mating at 37°C for 12--18 h. Bacteria were washed from the filter membrane and spotted on Muller-Hinton (MH) agar (BD Biosciences) plates containing 1,000 µg/mL rifampin together with indicated additional antibiotics for selecting an *E. coli* transconjugant carrying one of the following resistance markers: 4 µg/mL meropenem for *bla*~NDM-1~ (pP10159-1), *bla*~IMP-4~ (pP10159-2) and *bla*~KPC-2~ (pP10159-3); 10 µg/mL chloramphenicol for *catB3* (pP10159-4); and 10 µg/mL azithromycin for *mph*(A) (pP10159-5).

Plasmid electroporation
-----------------------

To prepare competent cells for plasmid electroporation, 200 mL of overnight culture of *E. coli* TOP10 in Super Optimal Broth (SOB) at an optical density (OD~600~) of 0.4 to 0.6 was washed three times with electroporation buffer (0.5 M mannitol and 10% glycerol) and concentrated into a final volume of 2 mL. One microgram of plasmid DNA, which was isolated from the P10159 strain using a Qiagen Plasmid Midi Kit, was mixed with 100 µL of competent cells for electroporation at 25 µF, 200 Ω and 2.5 Kv. The resulting cells were suspended in 500 µL of SOB and an appropriate aliquot was spotted on SOB agar plates containing the above indicated antibiotics for selecting of an *E. coli* electroporant carrying one of *bla*~NDM-1~, *bla*~IMP-4~, *bla*~KPC-2~, *catB3* and *mph*(A).

Detection of carbapenemase activity
-----------------------------------

Activity of class A/B/D carbapenemases in bacterial cell extracts was determined via a modified CarbaNP test.[@b12-idr-11-1447] Overnight bacterial cell culture in MH broth was diluted 1:100 into 3 mL of fresh MH broth and bacteria were allowed to grow at 37°C with shaking at 200 rpm to reach an OD~600~ of 1.0 to 1.4. If required, ampicillin was used at 200 µg/mL. Bacterial cells were harvested from 2 mL of the above culture and washed twice with 20 mM Tris-HCl (pH 7.8). Cell pellets were resuspended in 500 µL of 20 mM Tris-HCl (pH 7.8) and lysed by sonication, followed by centrifugation at 10,000 × g at 4°C for 5 minutes. Fifty microliters of the supernatant (the enzymatic bacterial suspension) were mixed with 50 µL of substrate I to V, respectively, followed by incubation at 37°C for 2 hours. Substrate I: 0.054% phenol red plus 0.1 mM ZnSO~4~ (pH7.8). Substrate II: 0.054% phenol red plus 0.1 mM ZnSO~4~ (pH7.8) and 0.6 mg/µL imipenem. Substrate III: 0.054% phenol red plus 0.1 mM ZnSO~4~ (pH7.8), 0.6 mg/µL mg imipenem and 0.8 mg/µL tazobactam. Substrate IV: 0.054% phenol red plus 0.1 mM ZnSO~4~ (pH7.8), 0.6 mg/µL mg imipenem and 3 mM EDTA (pH7.8). Substrate V: 0.054% phenol red plus 0.1 mM ZnSO~4~ (pH7.8), 0.6 mg/µL mg imipenem, 0.8 mg/µL tazobactam and 3 mM EDTA (pH7.8).

Bacterial antimicrobial susceptibility test
-------------------------------------------

Bacterial antimicrobial susceptibility was tested by the broth dilution method and interpreted as per Clinical and Laboratory Standards Institute (CLSI) guidelines.[@b13-idr-11-1447]

Nucleotide sequence accession numbers
-------------------------------------

The pP10159-1, pP10159-2, pP10159-3, pP10159-4 and pP10159-5 sequences were submitted to GenBank under accession numbers MF072961 to MF072965, respectively.

Results
=======

*C. freundii* co-harboring five resistance plasmids *C. freundii*
-----------------------------------------------------------------

P10159 belonged to a novel ST252, with an allelic profile 108--62--71--7--1--1--57 corresponding to the seven housekeeping genes *aspC*, *clpX*, *fadD*, *mdh*, *arcA*, *dnaG*, and *lysP*. High-throughput sequencing with the genomic DNA of the P10159 strain revealed the circularly closed sequences of the five plasmids pP10159-1, pP10159-2, pP10159-3, pP10159-4 and pP10159-5, 42.8 kb to 228.7 kb in length with 53 to 270 predicted open reading frames (ORFs) ([Figure S1](#SD1-idr-11-1447){ref-type="supplementary-material"} and [Table 1](#t1-idr-11-1447){ref-type="table"}). The modular structure of each plasmid was divided into the backbone regions and separate accessory modules, which were defined as acquired DNA regions associated with and bordered by mobile elements ([Figure S1](#SD1-idr-11-1447){ref-type="supplementary-material"} and [Table 1](#t1-idr-11-1447){ref-type="table"}). Some of these accessory modules harbored drug resistance genes ([Table 2](#t2-idr-11-1447){ref-type="table"}).

pP10159-1, pP10159-2 and pP10159-3 could be transferred into *E. coli* through conjugation or electroporation, which generated the corresponding transconjugants NDM-EC600, IMP-EC600 and KPC-EC600 plus the respective electroporants NDM-TOP10, IMP-TOP10 and KPC-TOP10 ([Table 3](#t3-idr-11-1447){ref-type="table"}). This assay indicated that these three plasmids were conjugative. Repeated attempts failed to transfer pP10159-4 or pP10159-5 into *E. coli* through conjugation and electroporation.

P10159 and all the transconjugants and transformants were resistant to ampicillin, ceftazidime, meropenem and cefoxitin ([Table 3](#t3-idr-11-1447){ref-type="table"}). P10159 had class A + B carbapenemase activity, while the transconjugants and transformants har-boring pP10159-1 or pP10159-2 had B activity and those harboring pP10159-3 had A activity ([Table S1](#SD4-idr-11-1447){ref-type="supplementary-material"}). These resistance phenotypes were consistent with the production of one or all of NDM, IMP and KPC enzymes in the corresponding strains.

Comparison of pP10159-1 with pNDM-HN380
---------------------------------------

pP10159-1 showed 99% nucleotide identity (with 100% query coverage) to nine *bla*~NDM~-carrying IncX3 plasmids, including the first fully sequenced pNDM-HN380[@b14-idr-11-1447] ([Figure 1A](#f1-idr-11-1447){ref-type="fig"}). pP10159-1/pNDM-HN380 contained three resistance genes *bla*~NDM-1~, *ble* and *bla*~SHV-12~, which were all located in the *bla*~NDM-1~ regions ([Figure 1B](#f1-idr-11-1447){ref-type="fig"}). The *bla*~NDM-1~ regions of pP10159-1/pNDM-HN380 were organized in order of a 4.1-kb truncated version of the composite transposon-like IS*26-bla*~SHV-12~-IS*26* unit,[@b15-idr-11-1447] a *bla*~NDM-1~-containingΔTn*125* element derived from the IS*Aba125*-flanked composite trans-poson Tn*125*,[@b16-idr-11-1447] IS*3000* and a 583-bp Tn*3* remnant ([Figure 1B](#f1-idr-11-1447){ref-type="fig"}). An inversion of the truncated IS*26-bla*~SHV-12~-IS*26* unit in the *bla*~NDM-1~regions represented the only modular difference between pP10159-1 and pNDM-HN380 ([Figure 1B](#f1-idr-11-1447){ref-type="fig"}).

Comparison of pP10159-2 with pP378-IMP
--------------------------------------

pP10159-2 displayed \>99% nucleotide identity (with \>97% query coverage) to 16 *bla*~IMP~-carrying IncN1 plasmids, including pIMP-HZ1[@b17-idr-11-1447] and pP378-IMP[@b18-idr-11-1447] ([Figure 2A](#f2-idr-11-1447){ref-type="fig"}). Although pIMP-HZ1 was the first fully sequenced *bla*~IMP~-carrying IncN1 plasmid, pP378-IMP[@b18-idr-11-1447] was more appropriate as the reference for genomic comparison because it contained two relatively complete mobile elements, namely a class 1 integron In823 and a truncated Tn*3*-family unit transposon ΔTn*6292*,[@b19-idr-11-1447] harboring *bla*~IMP-4~ and *qnrS1*, respectively. pP10159-2 and pP378-IMP shared the same In823 and also two resistance genes *bla*~IMP-4~ and *qnrS1*.

There were two major modular differences between pP10159-2 and pP378-IMP. First, the CUP (conserved upstream repeat)-controlled regulon[@b18-idr-11-1447] was composed of seven sequentially arranged operons CUPA, CUPB, CUP5, CUP4, CUP3, CUP2 and CUP1 in the backbone of pP10159-2, while the translocation of the CUP2 operon occurred in pP378-IMP ([Figure 2B](#f2-idr-11-1447){ref-type="fig"}). Second, the core transposition module *tnpA* (transposase)-*res* (resolution site)-*tnpR* (resolvase) of Tn*6292* was interrupted by IS*Kpn19*, breaking *tnpA* into separate ∆*tnpA-3*′ and ∆*tnpA-5*′,[@b18-idr-11-1447] whereas distinct additional deletion events occurred within the *tnpA-res-tnpR* modules of the ∆Tn*6292* elements from P10159-2 and pP378-IMP ([Figure 2C](#f2-idr-11-1447){ref-type="fig"}).

Comparison of pP10159-3 with pHS062105-3 and pECN49-KPC
-------------------------------------------------------

pP10159-3, pHS062105-3 and pECN49-KPC constituted a novel group of plasmids with almost identical backbones (\>99% query coverage and \>99% nucleotide identity). Their key backbone gene loci included *repA* for plasmid replication initiation, *parA* for plasmid partition, a toxin-antitoxin system *relEB* for post-segregational killing and a P-type IV secretion system for plasmid conjugal transfer ([Figures S1C](#SD1-idr-11-1447){ref-type="supplementary-material"} and [3A](#f3-idr-11-1447){ref-type="fig"}). Their RepA proteins belonging to the Rep_3 superfamily (pfam10134) and matched the RepA proteins from *Klebsiella pneumoniae* and *Pantoea stewartii* with \>96% query coverage and \>99% amino acid identity; all these RepA proteins could not be assigned into any known incompatibility groups.

The insertion of the core *bla*~KPC~ platform (ie, the Tn*6376* to Δ*repB* region) into the cryptic Tn*3*-family transposon Tn*1722*, truncating and splitting it into ΔTn*1722-5*′ and ΔTn*1722-3*′, generated Tn*6296* ([Figure 3B](#f3-idr-11-1447){ref-type="fig"}) as initially observed in pKP048.[@b20-idr-11-1447] Each of pP10159-3, pHS062105-3 and pECN49-KPC carried a single accessory region ΔTn*6296*, which carried the *bla*~KPC-2~ gene serving as the sole resistance determinant of these plasmids ([Figure 3B](#f3-idr-11-1447){ref-type="fig"}). The three ΔTn*6296* elements of pP10159-3, pHS062105-3 and pECN49-KPC had undergone deletions and insertions relative to the prototype Tn*6296*: 1) ΔTn*1722-3*′ was lost from all the three ΔTn*6296* elements; 2) a 123-bp deletion at the 3′-terminal region of Tn*6376* was found in pP10159-3; and 3) a 1,754-bp deletion within ΔTn*1722-5*′ as well as a 73-bp insertion within the variable number tandem repeat (VNTR) region of *orf396* was identified in pECN49-KPC. Notably, the above variations within ΔTn*6296* accounted for the only modular difference between pHS062105-3, pP10159-3 and pECN49-KPC.

Comparison of pP10159-4 with pNDM-CIT
-------------------------------------

The pP10159-4 backbone was highly similar (98% query coverage and 98% nucleotide identity) to the reference IncHI4 plasmid pNDM-CIT.[@b19-idr-11-1447],[@b21-idr-11-1447] pP10159-4 and pNDM-CIT shared the core IncHI4 backbone gene loci,[@b19-idr-11-1447] including *repHI4A* and *repHI4B* for replication initiation, *parAB* and *parMR* for partition, and the *tra1* and *tra2* regions for conjugal transfer. There were two major modular differences between these two backbones ([Figure S2](#SD2-idr-11-1447){ref-type="supplementary-material"}): 1) the deletion of an 11-gene region \[downstream of IS*Kpn26*; containing the arsenic resistance (*ars*) locus\] and a 4-gene region (downstream of IS*Kpn34*) from pP10159-4 relative to pNDM-CIT, and 2) the deletion of a distinct 4-gene region (downstream of IS*Lad2*) from pNDM-CIT compared with pP10159-4. These large-fragment deletions might result from the insertion of the corresponding IS elements IS*Kpn26*, IS*Kpn34* and IS*Lad2*. Of the accessory regions of pP10159-4, only the 25.3-kb MDR region and the 2.9-kb *bla*~CTX-M-3~ region contained the resistance genes ([Tables 1](#t1-idr-11-1447){ref-type="table"} and [2](#t2-idr-11-1447){ref-type="table"}).

The MDR region ([Figure 4](#f4-idr-11-1447){ref-type="fig"}) of pP10159-4 was organized as IS*1R*, a 14.1-kb 11-gene region encoding unknown functions, ΔIS*1R*, IS*Kpn19*, ΔIS*Pa38*, *orf402* (hypothetical protein), *orf291* (DNA polymerase), ΔTn*6308* and IS*Kpn19*. The unit transposon Tn*6308* belonged to the Tn*21* subgroup of the Tn*3* family and was initially identified in plasmid pP10164-3.[@b22-idr-11-1447] Tn*6308* ([Figure 4](#f4-idr-11-1447){ref-type="fig"}) had a hybrid backbone, which was composed of the core transposition module *tnpAR-res* of Tn*1696* and the mercury resistance (*mer*) region of Tn*21* and bordered by an intact 38-bp IRL and an IS*5075*-disrupted IRR (inverted repeat right); the class 1 integron In37 was inserted into the *res* site of Tn*6308*, truncating it from an original 120-bp fragment into an 83-bp remnant. Compared with the prototype class 1 integron, In37 in Tn*6308* had a very complex mosaic structure and had undergone two major events: 1) an IS*26*-flanked composite transposon Tn*6309*, carrying the class C tetracycline resistance module *tetA*(C)-*tetR*(C), was inserted into *intI1*; and 2) an 8.1-kb region (8KR) was inserted at a site between 3′-conserved segment (3′-CS), and the Tn*402 tni* module, leading to truncation of 3′-CS and *tni*. 8KR included the chromate-resistance unit IRL*~chrA~-chrA-orf98* and the macrolide-resistance unit IS*26-mph*(A)-*mrx-mphR*(A)-IS*6100*;[@b23-idr-11-1447] IRL*~chrA~* was further disrupted by IS*5075* in 8KR. Tn*6309*, a 217-bp region containing *attI1*, and a 15.5-kb region (8KR-Δ*tniA-mer*:IS*5075*-IRR~Tn6308~) were not found in ΔTn*6308* of pP10159-4 relative to Tn*6308*.

IS*Ecp1* was able to capture and arrange *bla*~CTX-M-3~-Δ*orf477* at its downstream end while it moved,[@b24-idr-11-1447] while the *bla*~CTX-M-3~ region of pP10159-4 was a close derivative of this IS*Ecp1*-base unit with truncation at its 3′-end region.

Comparison of pP10159-5 with pR55
---------------------------------

pP10159-5 shared 94% of its backbone with the reference type 2 IncC plasmid pR55,[@b25-idr-11-1447] with 99% nucleotide identity. All the type 2 IncC signature sequences, including two small insertions i1 and i2 as well as two genes *orf1847* and *rhs2*,[@b26-idr-11-1447] were found in pR55 and pP10159-5, with the only exception that a 246-bp deletion occurred at the 3′-terminus of *rhs2* in pP10159-5 ([Figure S1E](#SD1-idr-11-1447){ref-type="supplementary-material"}). pP10159-5 and pR55 possessed the core IncC backbone gene loci including *repA* for replication initiation, *parAB* and *parM* for partition, and the *tra1* and *tra2* regions for conjugal transfer ([Figure S1E](#SD1-idr-11-1447){ref-type="supplementary-material"}).

Linear sequence comparison of pP10159-5 and pR55 revealed five different regions (DIERs), namely DIER-1 to DIER-5 ([Figure S3](#SD3-idr-11-1447){ref-type="supplementary-material"}). DIER-1 was located between *orf564* and *orf312*, and manifested as the *traE* and *orf225* region composed of a 3′-terminal Tn*6292*[@b18-idr-11-1447] remnant (designated ΔTn*6292*; harboring no resistance genes) and eight con jugal transfer genes \[found in another type 2 IncC plasmid pSRC119-A/C[@b27-idr-11-1447] but not in pR55\] in pP10159-5; however, DIER-1 was manifested as the *orf546* to *sul2* region carrying the *floR* (florfenicol/chloramphenicol resistance)-IS*CR2* region and five putative plasmid maintenance genes in pR55. DIER-2 existed as the *orf861* to *orf852* region (consisting of 34 putative plasmid maintenance genes) in pR55 and was deleted due to the insertion of *ISEc52* at a site between *traN* and *orf147* in pP10159-5; the *ISEc52* insertion also resulted in the truncation of *traN* in pP10159-5. The loss of the *orf861* to *orf852* region, a part of the plasmid maintenance region as observed in pR55, did not destroy the plasmid maintenance of pP10159-5. A 58.2-kb MDR region (DIER-3) was inserted into *rhs2* in pP10159-5 relative to pR55, leading to the truncation of *rhs2* as well as the deletion of the downstream *orf273-orf243* region. The Tn*3*-family unit transposon Tn*6187* (DIER-4; 32.6 kb in length) was inserted into *orf492* in pR55 relative to pP10159-5, splitting *orf492* into two separate parts and meanwhile leaving 5-bp direct repeats (DRs; target site duplication signals of transposition) at both ends of Tn*6187*. The *traF* to *orf186* region (DIER-5; containing not only conjugal transfer but plasmid maintenance genes) was located between *uvrD* and *mobI* in pR55, but replaced by a second copy of IS*Ec52* in pP10159-5; the IS*Ec52* insertion further led to the truncation of *uvrD* in pP10159-5. These five DIERs were associated with not only accessory modules but backbone regions, and the insertion and deletion events occurred within the two conjugal transfer regions *tra1* and *tra2* of pP10159-5 would cause this plasmid to be non-conjugative.

All the resistance genes of pP10159-5 were harbored in the MDR region ([Figure 5](#f5-idr-11-1447){ref-type="fig"}), which was sequentially organized as IS*1R*, a 3.6-kb 7-gene region of unknown functions, a 9.6-kb *bla*~SFO-1~ (β-lactam resistance) region as observed in pHD0149-2,[@b28-idr-11-1447] the *chrA*- and *mph*(A)-carrying 8KR fragment as found in In37 of Tn*6308*,[@b22-idr-11-1447] a 15-kb *aacC2* (aminoglycoside resistance)-*tmrB* (tunicamycin resistance) region that was generated from the insertion of a 7-kb phage-related region at a site between IS*Cfr1* and *bla*~TEM-1~ (β-lactamase resistance) of the original *aacC2-tmrB* region as identified in pEl1573,[@b29-idr-11-1447] a 7.4-kb Tn*21* remnant that was the 3′-terminal IRR to Δ*tniA* region (containing the *mer* locus) of Tn*21*[@b30-idr-11-1447] with the disruption of IRR by IS*4321R* and a Tn*1548*-associated region.

Tn*1548* was a IS*26*-flanked composite transposon lacking DRs at its ends, and had an IS*26*-In27-IS*CR1*-ΔIS*Ec28-armA* (aminoglycoside resistance)-IS*Ec29-msr*(E)-*mph*(E) (macrolide resistance)-*orf543-repAciN*-IS*26* structure. There were a number of Tn*1548*-associated elements with the replacement of In27 by different class 1 integrons,[@b31-idr-11-1447] eg, In0 carrying no gene cassette array in pP10159-5 ([Figure 5](#f5-idr-11-1447){ref-type="fig"}).

Remarkably, pP10159-5/pR55 belonged to the same incompatibility group and were genetically very closed related with respect to their plasmid backbones, but they carried totally different profiles of accessory modules that were inserted at different sites of the plasmid backbones; a similar observation was also found for pP10159-4/pNDM-CIT.

Discussion
==========

*C. freundii* isolates are resistant to cephalosporins due to inducible expression of chromosomally encoded AmpC β-lactamase,[@b32-idr-11-1447] but in general still remain susceptible to carbapenems. *C. freundii* can persist in the hosts for long periods, which likely facilitates the acquisition and accumulation of various resistance determinants under high selective pressure within the hospital environments. Carbapenem-resistant *C. freundii* isolates expressing plasmid-encoding carbapenemases, such as KPC,[@b33-idr-11-1447] NDM,[@b34-idr-11-1447] and VIM,[@b35-idr-11-1447] have emerged during the past decade and, moreover, the coproduction of two or more carbapenemases, eg, KPC-2 + NDM-1[@b36-idr-11-1447] and NDM-1 + VIM-4 + OXA-181,[@b37-idr-11-1447] have also been identified in *C. freundii*, making the corresponding isolates highly resistant to β-lactams including carbapenems.

Coexistence of two to four different resistance plasmids has been observed in *C. freundii*.[@b36-idr-11-1447],[@b38-idr-11-1447],[@b39-idr-11-1447] We recently determined the complete nucleotide sequences of four plasmids p112298-KPC (belonging to an unknown incompatibility group; accession number KP987215),[@b36-idr-11-1447] p112298-NDM (IncX3 type; KP987216),[@b36-idr-11-1447] p112298-catA (IncHI2; KY270851) and p112298-tetA (type 1 IncC)[@b40-idr-11-1447] coexisting in a clinical *C. freundii* isolate 112,298. In this follow-up study, high-throughput genomic sequencing disclosed the co-occurrence of five resistance plasmids pP10159-1, pP10159-2, pP10159-3, pP10159-4 and pP10159-5 in a clinical *C. freundii* isolate P10159. This is the first report of co-occurrence of five resistance plasmids of different incomparability groups, with determination of their complete sequences, coexisting in a bacterial isolate.

There is the increasing prevalence of MDR *C. freundii* strains, which resulted from co-selection of genes encoding resistance to multiple antimicrobial classes, thereby leaving few or no options of antimicrobial treatment.[@b36-idr-11-1447],[@b38-idr-11-1447],[@b39-idr-11-1447] In this study, the five plasmids from *C. freundii* P10159 contain a total of 24 different genes or gene loci involved in the resistance to β-lactams including carbapenems, aminoglycosides, quinolones, macrolides, phenicols, rifampicin, sulfonamides, tunicamycin, bleomycin, quaternary ammonium compounds, chromate, mercury and tellurium, which are associated with several mobile elements including insertion sequences, integrons and transposons. Notably, the existence of redundant resistance genes made the P10159 strain extremely highly resistant to the corresponding classes of antibiotics, including carbapenems (*bla*~NDM-1~, *bla*~IMP-4~ and *bla*~KPC-2~), aminoglyco-sides (*armA* and *aacC2*), quinolones (*qnrS1* and *aacA4cr*), macrolides \[*mph*(A) and *mph*(E)\] and sulfonamides (two copies of *sul1*).

The co-selection and maintenance of multiple plasmids and an extremely large number of resistance genes in a single bacterial isolate reflect active and complex horizontal genetic transfer events that have taken place under selective pressures associated with many kinds of antibiotic molecules or toxic compounds.

Supplementary material
======================

###### 

Plasmid schematic maps.

**Notes:** The nine plasmids pP10159-1 and pNDM-HN380 (**A**), pP10159-2 and pP378-IMP (**B**), pP10159-3, pHS062105-3 and pECN49-KPC (**C**), pP10159-4 and pNDM-CIT (**D**), and pP10159-5 and pR55 (**E**) are included in the comparative analysis. Genes are denoted by arrows, and the backbone and accessory module regions are highlighted in black and color, respectively. The innermost circle presents GC-skew \[(G-C)/(G + C)\], with a window size of 500 bp and a step size of 20 bp. The next-to-innermost circle presents GC content.

###### 

Linear comparison of pP10159-4 and pNDM-CIT sequences.

**Notes:** Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity).

###### 

Linear comparison of pP10159-5 and pR55 sequences.

**Notes:** Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity).

###### 

Results of modified CARBA-NP test

  --------------------------------------------------------------------------------------------------
  Bacterial strain   Substrate   Detecting carbapenemase activity\                           
                                 (Ambler class)                                              
  ------------------ ----------- ----------------------------------- -------- -------- ----- -------
  P10159             Red         Yellow                              Yellow   Yellow   Red   A + B

  NDM-EC600          Red         Yellow                              Yellow   Red      Red   B

  NDM-TOP10          Red         Yellow                              Yellow   Red      Red   B

  IMP-EC600          Red         Yellow                              Yellow   Red      Red   B

  IMP-TOP10          Red         Yellow                              Yellow   Red      Red   B

  KPC-EC600          Red         Yellow                              Red      Yellow   Red   A

  KPC-TOP10          Red         Yellow                              Red      Yellow   Red   A

  TOP10              Red         Red                                 Red      Red      Red   --

  EC600              Red         Red                                 Red      Red      Red   --
  --------------------------------------------------------------------------------------------------
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![Comparison of pP10159-1 with pNDM-HN380.\
**Notes:** Shown are linear comparison of the two sequenced plasmids pP10159-1 and pNDM-HN380 (**A**), and that of the *bla*~NDM-1~ regions of these two plasmids (**B**). Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity). Numbers in brackets indicate the nucleotide positions within the corresponding plasmids.](idr-11-1447Fig1){#f1-idr-11-1447}

![Comparison of pP10159-2 with pP378-IMP.\
**Notes:** Shown are linear comparison of the two sequenced plasmids pP10159-2 and pP378-IMP (**A**), that of the CUP regions of these two plasmids (**B**), and that of the Tn*6292*-associated regions of these two plasmids (**C**). Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity). Numbers in brackets indicate the nucleotide positions within the corresponding plasmids.](idr-11-1447Fig2){#f2-idr-11-1447}

![Comparison of pP10159-3 with pHS062105-3 and pECN49-KPC.\
**Notes:** Shown are linear comparison of the three sequenced plasmids pP10159-3, pHS062105-3 and pECN49-KPC (**A**), and that of Tn*6296* and its three derivatives from these thee plasmids (**B**). Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity). Numbers in brackets indicate the nucleotide positions within the corresponding plasmids.](idr-11-1447Fig3){#f3-idr-11-1447}

![The MDR region from pP10159-4 and comparison with related regions.\
**Notes:** Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity). Numbers in brackets indicate the nucleotide positions within the corresponding plasmids.\
**Abbreviation:** MDR, multi-drug resistant.](idr-11-1447Fig4){#f4-idr-11-1447}

![The MDR region from pP10159-5 and comparison with related regions.\
**Notes:** Genes are denoted by arrows. Genes, mobile elements and other features are colored based on function classification. Shading denotes regions of homology (\>95% nucleotide identity). Numbers in brackets indicate the nucleotide positions within the corresponding plasmids.\
**Abbreviation:** MDR, multi-drug resistant.](idr-11-1447Fig5){#f5-idr-11-1447}

###### 

Major features of plasmids analyzed

  Category                      Plasmid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ----------------------------- ---------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------- -------- --------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- ------------- ---------
  Incompatibility group         IncX3                                                                                                                                                                                                                IncN1                                                            Unknown                                                                                                                                                                                                                                                                                                                                                                                         IncHI4                                                                                                                                                                                                                                          Type 2 IncC   
  Total length (bp)             54,034                                                                             54,035                                                                                                                            51,104                                                  51,207   42,763    42,848                                                                                                                                                                                                              41,317                                                                                                                                                            228,709                                                                                                        288,920                                                                                                                          152,132       170,810
  Total number of ORFs          62                                                                                 62                                                                                                                                62                                                      64       53        53                                                                                                                                                                                                                  52                                                                                                                                                                270                                                                                                            314                                                                                                                              190           203
  Mean G + C content, %         49.0                                                                               49.0                                                                                                                              50.4                                                    50.5     49.8      49.7                                                                                                                                                                                                                49.1                                                                                                                                                              47.0                                                                                                           47.7                                                                                                                             51.1          53.0
  Length of the backbone (bp)   34,731                                                                             34,732                                                                                                                            37,474                                                  37,345   29,082    29,043                                                                                                                                                                                                              29,043                                                                                                                                                            190,385                                                                                                        208,301                                                                                                                          89,438        129,510
  Accessory modules             The *bla*~NDM-1~ region[\#](#tfn2-idr-11-1447){ref-type="table-fn"} and IS*Kox3*   In823b[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, ΔTn*6292*[\#](#tfn2-idr-11-1447){ref-type="table-fn"} and the IS*1* remnant   ΔTn*6296*[\#](#tfn2-idr-11-1447){ref-type="table-fn"}                      The MDR region[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, the *bla*~CTX-M-3~ region[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, IS*Lad2*, IS*Kpn26*-IS*1R*, IS*Cfr4*-ΔIS*Cfr9*, IS*903B* and IS*Cfr6*:IS*Ec21*   The MDR region[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, ΦCP4-6/57[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, IS*Kpn26*, IS*Kpn34*, ΔIS*Cfr9* and IS*Sen3*   The MDR region[\#](#tfn2-idr-11-1447){ref-type="table-fn"}, ΔTn*6292*-3′ and two separate copies of IS*Ec52*   The *floR*-IS*CR2* region[\#](#tfn2-idr-11-1447){ref-type="table-fn"} and Tn*6187*[\#](#tfn2-idr-11-1447){ref-type="table-fn"}                 

**Notes:** pP10159-1, pP10159-2, pP10159-3, pP10159-4 and pP10159-5 from *C. freundii* P10159 were sequenced in this work, while the other plasmids were derived from GenBank and used as references. Sequence comparison of each of these five sequenced plasmids with their reference plasmid(s) was interpreted in the text.

These accessory modules contained resistance genes as listed in [Table 2](#t2-idr-11-1447){ref-type="table"}.

**Abbreviation:** MDR, multi-drug resistant.

###### 

Drug resistance genes in plasmids analyzed

  Plasmid           Resistance gene                           Resistance phenotype     Nucleotide position in plasmid   Accessory or backbone region located
  ----------------- ----------------------------------------- ------------------------ -------------------------------- --------------------------------------
  pP10159-1         *bla*~SHV-12~                             Beta-lactam resistance   9,324--10,184                    The *bla*~NDM-1~ region
  *ble*             Bleomycin resistance                      17,458--17,823                                            
  *bla*~NDM-1~      Beta-lactam resistance                    17,827--18,639                                            
  pP10159-2         *bla*~IMP-4~                              Beta-lactam resistance   4,295--5,035                     In823b
  *qnrS1*           Quinolone resistance                      27,662--28,318           ΔTn*6292*                        
  pP10159-3         *bla*~KPC-2~                              Beta-lactam resistance   7,737--8,618                     ΔTn*6296*
  pP10159-4         *aacA4cr*                                 Quinolone resistance     85,056--85,655                   The MDR region
  *bla*~OXA-1~      Beta-lactam resistance                    85,786--86,616                                            
  *catB3*           Phenicol resistance                       86,754--87,386                                            
  *arr3*            Rifampicin resistance                     87,471--87,923                                            
  *qacE*Δ*1*        Quaternary ammonium compound resistance   88,146--88,493                                            
  *sul1*            Sulfonamide resistance                    88,487--89,326                                            
  *bla*~CTX-M-3~    Beta-lactam resistance                    114,790--115,665         The *bla*~CTX-M-3~ region        
  The *ter* locus   Tellurium resistance                      116,056--136,305         The plasmid backbone             
  pP10159-5         *bla*~SFO-1~                              Beta-lactam resistance   87,807--88,694                   The MDR region
  *chrA*            Chromate resistance                       98,473--99,678                                            
  *mph*(A)          Macrolide resistance                      103,297--104,202                                          
  *aacC2*           Aminoglycoside resistance                 105,261--106,121                                          
  *tmrB*            Tunicamycin resistance                    106,134--106,676                                          
  *bla*~TEM-1~      Beta-lactam resistance                    118,230--119,090                                          
  The *mer* locus   Mercuric resistance                       120,698--124,660                                          
  *qacE*Δ*1*        Quaternary ammonium compound resistance   128,336--128,683                                          
  *sul1*            Sulfonamide resistance                    128,677--129,516                                          
  *armA*            Aminoglycoside resistance                 132,848--133,621                                          
  *msr*(E)          Macrolide resistance                      135,920--137,395                                          
  *mph*(E)          Macrolide resistance                      137,451--138,335                                          

**Abbreviation:** MDR, multi-drug resistant.

###### 

Antimicrobial drug susceptibility profiles

  Antibiotics        MIC (mg/L)/antimicrobial susceptibility                                                                                     
  ------------------ ----------------------------------------- ----------- ----------- ----------- ---------- ----------- ----------- ---------- ----------
  Ampicillin         \>1,024/R                                 \>1,024/R   \>1,024/R   512/R       256/R      \>1,024/R   \>1,024/R   \<4/S      \<4/S
  Ceftazidime        \>512/R                                   \>512/R     \>512/R     \>512/R     512/R      64/R        16/R        \<4/S      \<4/S
  Imipenem           64/R                                      64/R        64/R        64/R        32/R       64/R        64/R        \<1/S      \<1/S
  Meropenem          64/R                                      16/R        8/R         4/R         4/R        32/R        4/R         \<1/S      \<1/S
  Cefoxitin          \>1,024/R                                 1,024/R     512/R       \>1,024/R   256/R      128/R       32/R        \<8/S      \<8/S
  Ciprofloxacin      64/R                                      \<1/S       \<1/S       2/I         2/I        \<1/S       \<1/S       \<1/S      \<1/S
  Amikacin           \>1,024/R                                 \<8/S       \<8/S       \<8/S       \<8/S      \<8/S       \<8/S       \<8/S      \<8/S
  Azithromycin       \>512/R                                   \<4/S       \<4/S       \<4/S       \<4/S      8/S         \<4/S       4/S        4/S
  Trimethoprime      \>32R                                     \<0.25/S    \<0.25/S    \<0.25/S    \<0.25/S   \<1/S       \<0.25/S    \<0.25/S   \<0.25/S
  Sulfamethoxazole   \>608/R                                   \<4.75/S    \<4.75/S    \<4.75/S    \<4.75/S   19/S        \<4.75/S    \<4.75/S   \<4.75/S
  Chloramphenicol    32/R                                      \<8/S       \<8/S       \<8/S       \<8/S      \<8/S       \<8/S       \<8/S      \<8/S
  Nitrofurantoin     16/S                                      16/S        \<4/S       16/S        \<4/S      32/S        \<4/S       \<4/S      8/S
  Minocycline        2/S                                       \<1/S       4/S         \<1/S       4/S        \<1/S       4/S         4/S        \<1/S
  Fosfomycin         \<64/S                                    \<64/S      \<64/S      \<64/S      \<64/S     \<64/S      \<64/S      \<64/S     \<64/S
  Tigecycline        \<1/S                                     \<1/S       \<1/S       \<1/S       \<1/S      \<1/S       \<1/S       \<1/S      \<1/S
  Colistin           \<1/S                                     \<1/S       \<1/S       \<1/S       \<1/S      \<1/S       \<1/S       \<1/S      \<1/S

**Abbreviations:** MIC, minimum inhibitory concentration; S, sensitive; *R*, resistant; I, intermediately resistant.

[^1]: These authors contributed equally to this work
